Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Leukaemia in Relapse”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00346359
What this trial is testing

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
Fred Hutchinson Cancer Center 40
Early research (Phase 1)Looking for participantsNCT07374029
What this trial is testing

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia, in Relapse
David Avigan 30
Testing effectiveness (Phase 2)Study completedNCT00003131
What this trial is testing

CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse

Who this might be right for
Leukemia
Pfizer 55
Large-scale testing (Phase 3)Study completedNCT03476239
What this trial is testing

Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen 121
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Testing effectiveness (Phase 2)Study completedNCT00005802
What this trial is testing

Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02017457
What this trial is testing

Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Carlos Graux, MD, PhD 50
Early research (Phase 1)Ended earlyNCT01159301
What this trial is testing

Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+16 more
National Cancer Institute (NCI) 44
Early research (Phase 1)Looking for participantsNCT05101551
What this trial is testing

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

Who this might be right for
Acute Myeloid Leukemia
Norman J. Lacayo 34
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)WithdrawnNCT01478074
What this trial is testing

ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Altor BioScience
Early research (Phase 1)Study completedNCT03194685
What this trial is testing

Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Fujifilm Pharmaceuticals U.S.A., Inc. 97
Early research (Phase 1)Ended earlyNCT05654779
What this trial is testing

CLL-1/CD33 Targeted LCAR-AMDR Cells in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 4
Testing effectiveness (Phase 2)Study completedNCT04079296
What this trial is testing

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome
Astellas Pharma Global Development, Inc. 43
Not applicableNot Yet RecruitingNCT07563920
What this trial is testing

TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 93
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Testing effectiveness (Phase 2)Study completedNCT02249091
What this trial is testing

A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (Relapsed/Refractory)
GSO Global Clinical Research BV 42
Testing effectiveness (Phase 2)UnknownNCT06532058
What this trial is testing

Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)
Changzhou Qianhong Bio-pharma Co., Ltd. 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT06232655
What this trial is testing

Cladribine Venetoclax in Monocytic AML

Who this might be right for
Acute Myeloid Leukemia
University of Colorado, Denver 10
Testing effectiveness (Phase 2)Looking for participantsNCT04150497
What this trial is testing

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Cellectis S.A. 52
Next Page